Seelos gets Nasdaq delisting notice Oct. 15, 2024 9:25 AM ET By: Preeti Singh , SA News Editor [Seeking Alpha]
Seelos Therapeutics, Inc. (SEEL)
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Stock Market for failure to comply with the minimum stockholder's equity requirement under Nasdaq Listing Rule 5550(b)(1). As previously disclosed, the Nasdaq Hearings Panel had provided the company until October 11, 2024, to regain compliance with the equity standard rule. Trading in the company's common stock will be suspended on Nasdaq effective with the open of business on October 16, 2024. As a result, Seelos Therapeutics ( SEEL ) expects its common stock to begin trading on the OTCQB on that date. Shares of the biopharmaceutical company fell ~40% premarket. Recommended For You Comments More Trending News Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
SEEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SEEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SEEL alerts
High impacting Seelos Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SEEL
News
- Seelos Announces Second Postponement of its Annual Meeting of StockholdersPR Newswire
- Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter MarketPR Newswire
- Seelos Therapeutics Announces 1-for-16 Reverse Stock SplitPR Newswire
- Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSDPR Newswire
SEEL
Sec Filings
- 11/14/24 - Form SC
- 11/5/24 - Form SC
- 10/24/24 - Form DEFA14A
- SEEL's page on the SEC website